Exscalate Foundation Holdings
Dompe Farmaceutici Logo
    • Who We Are
      • History
      • Management Team
      • Environment, Quality & Safety
      • Ethics and Compliance
    • Where We Are
      • Manufacturing Biotech
      • Manufacturing Pharma
      • Offices
    • Discover more - About Us
    • Nerve Growth Factor
    • Pipeline
    • Disease Focus
      • Neurotrophic keratitis (NK)
      • Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
      • Atopic Kerato-conjunctivitis (AKC)
    • Exscalate
    • Discover more - Science
    • Primary & Specialty Care
      • Pain and Anti-inflammatory
      • Cold, Flu & Cough
      • Gastro
      • Cardiovascular
      • Eye, Skin & Oral Care
      • Prevention
    • Ophthalmics
    • Managed Access Programs
    • Discover more - Medicines
    • News & Announcements
    • Press Office
    • Discover more - Media
    • People & Culture
    • Join Us
    • Discover more - Careers
  • Global
  • IT
  • US

Mobile Navigation Menu

    • Who We Are
      • History
      • Management Team
      • Environment, Quality & Safety
      • Ethics and Compliance
    • Where We Are
      • Manufacturing Biotech
      • Manufacturing Pharma
      • Offices
    • Discover more - About Us
    • Nerve Growth Factor
    • Pipeline
    • Disease Focus
      • Neurotrophic keratitis (NK)
      • Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
      • Atopic Kerato-conjunctivitis (AKC)
    • Exscalate
    • Discover more - Science
    • Primary & Specialty Care
      • Pain and Anti-inflammatory
      • Cold, Flu & Cough
      • Gastro
      • Cardiovascular
      • Eye, Skin & Oral Care
      • Prevention
    • Ophthalmics
    • Managed Access Programs
    • Discover more - Medicines
    • News & Announcements
    • Press Office
    • Discover more - Media
    • People & Culture
    • Join Us
    • Discover more - Careers
  • Global
  • IT
  • US
Suggested topics:
  1. Home >
  2. Medicines

Medicines

Explore our Medicines section to learn about our available treatments and stay updated on the latest pharmaceutical advancements.

  • Checking on the inventory

    Primary & Specialty Care

    Our primary care and over-the-counter products address a wide range of common conditions, from pain and inflammation to eye, skin, and oral care, as well as remedies for heart and stomach issues

    Learn more
  • Herobanner Ophtalmics.jpg

    Ophthalmics

    At Dompé, our R&D strives to address areas of unmet clinical need. This is what led us to discover a treatment for a rare eye disease. Having brought this innovative therapy to eyecare, our research in this therapeutic area continues to expand

    Learn more
  • Managed Access Programs

    Dompé’s Managed Access Programs provide investigational or unavailable medicines to individual patients, upon physician request, through approved local access channels such as compassionate use or special access

    Learn more
Dompé
Pharmaco-vigilance and Vigilance Contact Privacy Policy Terms and Conditions Cookie Policy Supplier Customer Information Accessibility Whistleblowing

Dompé farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153.
This website contains information on products that are targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. 

© 2025 Dompé. All rights reserved.

  • Global
  • IT
  • US